Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: A comparative study between iron saccharate and gluconate

Nephron - Clinical Practice

Volumn 99, Issue 4, 2005, Pages

  Sheashaa, Hussein ^a   El Husseini, Amr ^a   Sabry, Alaa ^a   Hassan, Nabil ^a   Salem, Ayman ^a   Khalil, Abdalla ^a   El Agroudy, Amgad ^a   Sobh, Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anemia; Hemodialysis; Iron gluconate; Parenteral iron saccharate

Indexed keywords

ERYTHROPOIETIN; FERRIC GLUCONATE; HEMOGLOBIN; IRON SACCHARATE;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEADACHE; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON STORAGE; IRON THERAPY; KIDNEY FAILURE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; ANEMIA, IRON-DEFICIENCY; FEMALE; FERRIC COMPOUNDS; GLUCONATES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PARENTERAL NUTRITION; RENAL DIALYSIS;

EID: 17144387520     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083766     Document Type: Article

References (21)

1. Horl WH: Is there a role for adjuvant therapy in patients being treated with epoetin? Nephrol Dial Transplant 1999;14(suppl 2):50-60.
2. Tilman Drücke: Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001;16(suppl 7):25-28.
3. Moore LW, Acchiardo S, Sargent JA, Burk L: Incidence, causes and treatment of iron deficiency anemia in hemodialysis patients. J Ren Nutr 1992;3:105-112.
4. Tinawi M, Martin KJ, Bastani B: Oral iron absorption test in patients on CAPD: Comparison of ferrous sulfate and a polysaccharide ferric complex. Nephron 1996;74:291-294.
5. Fletes R, Lazarus M, Gage J, Chertow G: Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis 2001;37:743-749.
6. Daugirdas JT, Depner TA: A nomogram approach to hemodialysis urea modeling. Am J Kidney Dis 1994;23:33-40.
7. Stoves J, Inglis H, Newstead CG: A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Nephrol Dial Transplant 2001;16:967-974.
8. National Kidney Foundation DOQI: Clinical practice guidelines for anemia of kidney disease. Am J Kidney Dis 2001;37:S182-S238.
9. Sobh M, Sheashaa H, Tantawy A, Ghoneim M: Study of effect of optimization of dialysis and protein intake on neuromuscular function in patients under maintenance hemodialysis. Am J Nephrol 1998;18:399-403.
10. EBPG: European Best Practice Guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 2000;15(suppl 4):57-63.
11. Bailie GR, Johnson CA, Mason NA: Parenteral iron use in the management of anemia in end-stage renal disease patients. Am J Kidney Dis 2000;35:1-12.
12. Nissenson AR, Lindsay RM, Swan S, Seligman P, Strobos J: Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients. Am J Kidney Dis 1999;33:471-482.
13. Faich G, Strobos J: Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 1999;33:464-470.
14. Van Wyck DB, Cavallo G, Spinowitz BS, et al: Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis 2000;36:88-97.
15. Coyne DW, Adkinson NF, Nissenson AR, Fishbane S, Agarwal R, Eschbach JW, Michael B, Folkert V, Battle D, Trout JR, Dahl N, Myirski P, Strobos J, Warnock DG: Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran sensitive and dextran tolerant patients. Kidney Int 2003;63: 217-224.
16. Bastani B, Rahman S, Gallen M: Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran. ASAIO J 2002;48:404-406.
17. Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, Agarwal R, Eschbach JW, Faladem SZ, Trout JR, Strobos J, Warnock DG: Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran. Kidney Int 2002;61:1830-1839.
18. St Peter WL, Lambrecht LJ, Macres M: Randomized crossover study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients. Am J Kidney Dis 1996;28: 523-528.
19. Zager RA, Johnson AC, Hanson SY, Wasse H: Parenteral iron formulation: A comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 2002;40:90-103.
20. Yee J, Besarab A: Iron sucrose: The oldest iron therapy becomes new. Am J Kidney Dis 2002; 40:1111-1121.
21. Zolezzi M: Intravenous iron saccharate complex. Guidelines for its use in the management of anemia of renal disease. Saudi J Kidney Dis Transplant 2003;14:129-133.